Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Enrique Ocio, MD, PhD, Marqués de Valdecilla University Hospital, Santander, Spain, outlines a discussion that took place at the International Myeloma Workshop (IMW) 2019, held in Boston, MA, on novel therapeutic targets and agents for the treatment of multiple myeloma.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.